Jiangsu, China

Shilong Fu

USPTO Granted Patents = 7 

 

Average Co-Inventor Count = 7.6

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Title: Innovator Spotlight: Shilong Fu of Jiangsu, China

Introduction

Shilong Fu is a notable inventor based in Jiangsu, China, recognized for his contributions to the field of biopharmaceuticals. With a total of six patents to his name, Fu's work primarily revolves around advancements in cancer treatment and innovative protein compositions that have significant implications in the medical industry.

Latest Patents

Among Shilong Fu's latest innovations is a patent for **Proteinaceous heterodimer and use thereof**. This patent details the development of proteinaceous heterodimers, alongside pharmaceutical compositions, medicaments, and kits that incorporate these heterodimers. The research provides methods for producing these heterodimers, expanding their potential applications in healthcare.

Another critical patent from Fu involves **Methods and compositions for cancer treatment**. This invention presents novel compositions and methodologies for treating cancer, utilizing an immunoconjugate in conjunction with a cytotoxic agent or therapy. This combination is noted for its synergistic effects, showcasing the potential for improved outcomes in cancer therapies.

Career Highlights

Shilong Fu currently works at Dingfu Biotarget Co., Ltd., where he applies his expertise in biotargeting and therapeutics. His innovative research and development efforts have positioned him at the forefront of advancements in cancer treatment and pharmaceutical compositions, making significant impacts in these essential areas of healthcare.

Collaborations

Throughout his career, Fu has collaborated with esteemed colleagues such as Ting Xu and Yan Luan, contributing to various research projects and fostering an environment of innovation within his team. Their collective efforts aim to push the boundaries of medical science, particularly in oncology and therapeutic development.

Conclusion

In summary, Shilong Fu's impressive portfolio as an inventor demonstrates his commitment to advancing medical science through innovative solutions. With ongoing research and an emphasis on effective cancer treatments, he continues to inspire future advancements in the biopharmaceutical landscape. As the industry evolves, Fu's contributions are sure to play a vital role in improving patient outcomes worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…